Interferons in rheumatoid arthritis: alterations in production and response related to disease activity - PubMed (original) (raw)
Interferons in rheumatoid arthritis: alterations in production and response related to disease activity
P J Hertzog et al. Clin Immunol Immunopathol. 1988 Aug.
Abstract
Various markers associated with the production of and response to interferons (IFNs) were studied in patients with either inactive rheumatoid arthritis (RA) or active RA, and in healthy subjects. The IFN markers assessed were serum and synovial fluid (SF) levels, the activity in peripheral blood leukocytes (PBL) of (2'-5') oligoadenylate synthetase (OAS), and the production in vitro by PBL of IFN-alpha/beta in response to Sendai virus or Poly(I):Poly(C) as inducers, and of IFN-gamma using PHA or Con A as inducers. IFN activity, tested by antiviral assays using two different cell lines, was not demonstrable in the serum of any patient with RA. The activity of (2'-5') OAS in PBL, which may indirectly indicate exposure of leukocytes to IFN, was increased in RA compared with healthy subjects, more so in patients with inactive RA. The production of IFN-alpha/beta by PBL in response to Sendai virus was low in active RA but high in inactive RA, relative to production in healthy subjects. The production of IFN-gamma by PBL in RA was lower than in healthy subjects, more so in active RA. Thus inactive RA (remission status) is marked by evidence of PBL having been influenced by interferon and being a state of augmented inducibility to an IFN-alpha/beta stimulus, whereas active RA is associated with low inducibility of PBL to an IFN stimulus, but no evidence of IFN production in vivo. Our findings underscore the relevance of interferon to remission/activity in rheumatoid arthritis.
Similar articles
- Intermittent interferonemia and interferon responses in multiple sclerosis.
Hertzog PJ, Wright A, Harris G, Linnane AW, Mackay IR. Hertzog PJ, et al. Clin Immunol Immunopathol. 1991 Jan;58(1):18-32. doi: 10.1016/0090-1229(91)90145-z. Clin Immunol Immunopathol. 1991. PMID: 1701372 - Interferon signals and monocytic sensitization of the interferon-γ signaling pathway in the peripheral blood of patients with rheumatoid arthritis.
Karonitsch T, von Dalwigk K, Steiner CW, Blüml S, Steiner G, Kiener HP, Smolen JS, Aringer M. Karonitsch T, et al. Arthritis Rheum. 2012 Feb;64(2):400-8. doi: 10.1002/art.33347. Arthritis Rheum. 2012. PMID: 21953607 - Do the interferons act singly or in combination?
Hughes TK, Baron S. Hughes TK, et al. J Interferon Res. 1987 Oct;7(5):603-14. doi: 10.1089/jir.1987.7.603. J Interferon Res. 1987. PMID: 2445858 Review. - Role of IFN-α in Rheumatoid Arthritis.
Lin CMA, Isaacs JD, Cooles FAH. Lin CMA, et al. Curr Rheumatol Rep. 2024 Feb;26(2):37-52. doi: 10.1007/s11926-023-01125-6. Epub 2023 Dec 5. Curr Rheumatol Rep. 2024. PMID: 38051494 Free PMC article. Review.
Cited by
- Occludin Regulates HIV-1 Infection by Modulation of the Interferon Stimulated OAS Gene Family.
Torices S, Teglas T, Naranjo O, Fattakhov N, Frydlova K, Cabrera R, Osborne OM, Sun E, Kluttz A, Toborek M. Torices S, et al. Mol Neurobiol. 2023 Sep;60(9):4966-4982. doi: 10.1007/s12035-023-03381-0. Epub 2023 May 20. Mol Neurobiol. 2023. PMID: 37209263 Free PMC article. - Association between type I interferon pathway activation and clinical outcomes in rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider.
Rodríguez-Carrio J, Burska A, Conaghan PG, Dik WA, Biesen R, Eloranta ML, Cavalli G, Visser M, Boumpas DT, Bertsias G, Wahren-Herlenius M, Rehwinkel J, Frémond ML, Crow MK, Ronnblom L, Vital E, Versnel M. Rodríguez-Carrio J, et al. RMD Open. 2023 Mar;9(1):e002864. doi: 10.1136/rmdopen-2022-002864. RMD Open. 2023. PMID: 36882218 Free PMC article. - Type I interferon pathway assays in studies of rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider.
Burska A, Rodríguez-Carrio J, Biesen R, Dik WA, Eloranta ML, Cavalli G, Visser M, Boumpas DT, Bertsias G, Wahren-Herlenius M, Rehwinkel J, Frémond ML, Crow MK, Ronnblom L, Conaghan PG, Versnel M, Vital E. Burska A, et al. RMD Open. 2023 Mar;9(1):e002876. doi: 10.1136/rmdopen-2022-002876. RMD Open. 2023. PMID: 36863752 Free PMC article. - Occludin regulates HIV-1 infection by modulation of the interferon stimulated OAS gene family.
Torices S, Teglas T, Naranjo O, Fattakhov N, Frydlova K, Cabrera R, Osborne OM, Sun E, Kluttz A, Toborek M. Torices S, et al. Res Sq [Preprint]. 2023 Jan 30:rs.3.rs-2501091. doi: 10.21203/rs.3.rs-2501091/v1. Res Sq. 2023. PMID: 36778388 Free PMC article. Updated. Preprint. - Expression of the OAS Gene Family Is Highly Modulated in Subjects Affected by Juvenile Dermatomyositis, Resembling an Immune Response to a dsRNA Virus Infection.
Musumeci G, Castrogiovanni P, Barbagallo I, Tibullo D, Sanfilippo C, Nunnari G, Pellicanò GF, Pavone P, Caltabiano R, Di Marco R, Imbesi R, Di Rosa M. Musumeci G, et al. Int J Mol Sci. 2018 Sep 17;19(9):2786. doi: 10.3390/ijms19092786. Int J Mol Sci. 2018. PMID: 30227596 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical